CUX2
Basic information
Region (hg38): 12:111034165-111350554
Previous symbols: [ "CUTL2" ]
Links
Phenotypes
GenCC
Source:
- developmental and epileptic encephalopathy, 67 (Strong), mode of inheritance: AD
- Lennox-Gastaut syndrome (Supportive), mode of inheritance: AD
- developmental and epileptic encephalopathy, 67 (Strong), mode of inheritance: AD
- developmental and epileptic encephalopathy, 67 (Strong), mode of inheritance: AD
- genetic developmental and epileptic encephalopathy (Moderate), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Developmental and epileptic encephalopathy 67 | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 29630738; 29795476 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (172 variants)
- Inborn_genetic_diseases (171 variants)
- Developmental_and_epileptic_encephalopathy,_67 (65 variants)
- CUX2-related_disorder (57 variants)
- not_specified (16 variants)
- Intellectual_disability (6 variants)
- See_cases (2 variants)
- Russell-Silver_syndrome (1 variants)
- Cone-rod_dystrophy (1 variants)
- Bilateral_tonic-clonic_seizure (1 variants)
- Hypertrophic_cardiomyopathy (1 variants)
- Autism_spectrum_disorder (1 variants)
- Developmental_and_epileptic_encephalopathy (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CUX2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000015267.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 56 | 62 | ||||
missense | 243 | 68 | 319 | |||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 7 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
Total | 1 | 3 | 257 | 124 | 10 |
Highest pathogenic variant AF is 6.2468e-7
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CUX2 | protein_coding | protein_coding | ENST00000261726 | 22 | 316531 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.00000193 | 124785 | 0 | 9 | 124794 | 0.0000361 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.18 | 615 | 881 | 0.698 | 0.0000575 | 9418 |
Missense in Polyphen | 161 | 324.11 | 0.49675 | 3372 | ||
Synonymous | 1.62 | 365 | 407 | 0.898 | 0.0000292 | 3110 |
Loss of Function | 6.67 | 6 | 63.2 | 0.0949 | 0.00000305 | 753 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000201 | 0.000129 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000479 | 0.0000464 |
European (Non-Finnish) | 0.0000461 | 0.0000441 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: May be a transcription factor involved in neural specification. Binds to DNA in a sequence-specific manner (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.118
Intolerance Scores
- loftool
- 0.280
- rvis_EVS
- -2.08
- rvis_percentile_EVS
- 1.6
Haploinsufficiency Scores
- pHI
- 0.247
- hipred
- Y
- hipred_score
- 0.711
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.227
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cux2
- Phenotype
- embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); cellular phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;short-term memory;positive regulation of gene expression;Golgi vesicle transport;positive regulation of dendrite morphogenesis;cognition;positive regulation of synapse assembly;positive regulation of dendritic spine morphogenesis;cellular response to organic substance;positive regulation of excitatory postsynaptic potential
- Cellular component
- Golgi membrane;nucleus;extracellular exosome
- Molecular function
- RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;sequence-specific DNA binding